CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1999 Publications

1-10   

 

11. A PSA cutoff on 4 is too high for many men.
Moul JW:
Contemporary Urology 15-33, July, 1999.

 

12. Prostate Cancer in the Late 1990's: Hormone Refractory Disease Options.
Moul JW, Lipo DR:
Urologic Nursing, 19(2):125-131, 1999.

 

13. Racial Differences in Tumor Volume and Prostate Specific Antigen among Radical Prostatectomy Patients.
Moul JW, Connelly RR, Mooneyhan RM, Zhang W, Sesterhenn IA, Mostofi FK, and McLeod DG:
The Journal of Urology, 162: 394-397, 1999.

 

14. Blinded Evaluation of Reverse-Transcriptase Chain Reaction (RT-PCR) Prostate Specific Antigen (PSA) Peripheral Blood Assay for Molecular Staging of Prostate Cancer.
Gao C, Maheshwari S, Dean RC, Tatum L, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW:
Urology, 53:714-721, 1999.

 

15. Detection of Circulating PSA-expressing Prostatic Cells in the Bone Marrow of Radical Prostatectomy Patients by Sensitive Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).
Gao C, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW:
J Urol, 161: 1076-1076, 1999.

 

16. 3-D Computer Simulated Prostate Models Lateral Prostate Biopsies Increase the Detection Rate of Prostate Cancer.
Bauer JJ, Zeng J, Weir J, Zhang W, Sesterhenn IA, Connelly RR, Mun SK, Moul JW:
Urology, 53:961-967, 1999.